Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study

Chul-Hyun Cho, Yong-Min Ahn, Se Joo Kim, Tae Hyun Ha, Hong Jin Jeon, Boseok Cha, Eunsoo Moon, Dong Yeon Park, Ji Hyun Baek, Hee-Ju Kang, Vin Ryu, Hyonggin An, Heon-Jeong Lee, Chul-Hyun Cho, Yong-Min Ahn, Se Joo Kim, Tae Hyun Ha, Hong Jin Jeon, Boseok Cha, Eunsoo Moon, Dong Yeon Park, Ji Hyun Baek, Hee-Ju Kang, Vin Ryu, Hyonggin An, Heon-Jeong Lee

Abstract

The Mood Disorder Cohort Research Consortium (MDCRC) study is designed as a naturalistic observational prospective cohort study for early-onset mood disorders (major depressive disorders, bipolar disorders type 1 and 2) in South Korea. The study subjects consist of two populations: 1) patients with mood disorders under 25 years old and 2) patients with mood disorders within 2 years of treatment under 35 years old. After successful screening, the subjects are evaluated using baseline assessments and serial follow-up assessments at 3-month intervals. Between the follow-up assessments, subjects are dictated to check their own daily mood status before bedtime using the eMood chart application or a paper mood diary. At the regular visits every 3 months, inter-visit assessments are evaluated based on daily mood charts and interviews with patients. In addition to the daily mood chart, sleep quality, inter-visit major and minor mood episodes, stressful life events, and medical usage pattern with medical expenses are also assessed. Genomic DNA from blood is obtained for genomic analyses. From the MDCRC study, the clinical course, prognosis, and related factors of early-onset mood disorders can be clarified. The MDCRC is also able to facilitate translational research for mood disorders and provide a resource for the convergence study of mood disorders.

Keywords: Bipolar disorder; Cohort study; Early mood disorders; MDCRC; Major depressive disorder.

Figures

Figure 1. The overall design of the…
Figure 1. The overall design of the MDCRC study. MDCRC: Mood Disorder Cohort Research Consortium.

References

    1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18:23–33.
    1. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry. 2003;54:208–215.
    1. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11–19.
    1. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV, 3rd, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995;274:1511–1517.
    1. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914–919.
    1. Jeon HJ, Lee JY, Lee YM, Hong JP, Won SH, Cho SJ, et al. Lifetime prevalence and correlates of suicidal ideation, plan, and single and multiple attempts in a Korean nationwide study. J Nerv Ment Dis. 2010;198:643–646.
    1. Abreu LN, Lafer B, Baca-Garcia E, Oquendo MA. Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Rev Bras Psiquiatr. 2009;31:271–280.
    1. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20:359–364.
    1. Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, et al. Transition to mania during treatment of bipolar depression. Neuropsychopharmacology. 2010;35:2545–2552.
    1. Niitsu T, Fabbri C, Serretti A. Predictors of switch from depression to mania in bipolar disorder. J Psychiatr Res. 2015;66-67:45–53.
    1. Larsen RJ. The stability of mood variability: a spectral analytic approach to daily mood assessments. J Pers Soc Psychol. 1987;52:1195–1204.
    1. Hopko DR, Armento ME, Cantu MS, Chambers LL, Lejuez C. The use of daily diaries to assess the relations among mood state, overt behavior, and reward value of activities. Behav Res Ther. 2003;41:1137–1148.
    1. Hedges SM, Jandorf L, Stone AA. Meaning of daily mood assessments. J Pers Soc Psychol. 1985;48:428–434.
    1. Ma Y, Xu B, Bai Y, Sun G, Zhu R. Daily mood assessment based on mobile phone sensing. Wearable and implantable body sensor networks (BSN), 2012 ninth international conference on. IEEE. 2012:142–147.
    1. Luxton DD, McCann RA, Bush NE, Mishkind MC, Reger GM. mHealth for mental health: integrating smartphone technology in behavioral healthcare. Prof Psychol Res Pr. 2011;42:505–512.
    1. Grunerbl A, Muaremi A, Osmani V, Bahle G, Ohler S, Troster G, et al. Smartphone-based recognition of states and state changes in bipolar disorder patients. IEEE J Biomed Health Inform. 2015;19:140–148.
    1. Faurholt-Jepsen M, Frost M, Vinberg M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as objective measures of bipolar disorder symptoms. Psychiatry Res. 2014;217:124–127.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Washington, DC: American Psychiatric Publishing; 2013.
    1. Altamura AC, Buoli M, Caldiroli A, Caron L, Cumerlato Melter C, Dobrea C, et al. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study. J Affect Disord. 2015;182:70–75.
    1. Altamura AC, Dell'Osso B, Berlin HA, Buoli M, Bassetti R, Mundo E. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2010;260:385–391.
    1. Altamura AC, Dell'Osso B, Mundo E, Dell'Osso L. Duration of untreated illness in major depressive disorder: a naturalistic study. Int J Clin Pract. 2007;61:1697–1700.
    1. Dell'Osso B, Cremaschi L, Palazzo C, Suardi N, Spagnolin G, Camuri G, et al. Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders. Int Clin Psychopharmacol. 2015;30:29–35.
    1. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63:942–947.
    1. Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387:1085–1093.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 34-57.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
    1. Young RC, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435.
    1. Giglio LM, Magalhães PV, Andreazza AC, Walz JC, Jakobson L, Rucci P, et al. Development and use of a biological rhythm interview. J Affect Disord. 2009;118:161–165.
    1. Guy W National Institute of Mental Health. Psychopharmacology Research Branch, Early Clinical Drug Evaluation Program. ECDEU assessment manual for psychopharmacology. Rockville, Md: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
    1. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573–583.
    1. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217–233.
    1. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873–1875.
    1. Barratt ES, Patton J, Stanford M. Barratt Impulsiveness Scale. Texas: Barratt-Psychiatry Medical Branch, University of Texas; 1975.
    1. Yoon BH, Bahk WM, Lee KU, Hong CH, Ahn JK, Kim MK. Psychometric properties of Korean version of drug attitude inventory (KDAI-10) Korean J Psychopharmacol. 2005;16:480–487.
    1. Rosenthal N, Bradt G, Wehr T. Seasonal Pattern Assessment Questionnaire. Bethesda: National Institute of Mental Health; 1987.
    1. Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness. J Appl Psychol. 1989;74:728–738.
    1. Min SK, Lee CI, Kim KI, Suh SY, Kim DK. Development of Korean version of WHO quality of life scale abbreviated version (WHOQOL-BREF) J Korean Neuropsychiatr Assoc. 2000;39:571–579.
    1. Lee PH, Macfarlane DJ, Lam T, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8:115.
    1. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978;46:932–946.
    1. Jeon HJ, Baek JH, Ahn YM, Kim SJ, Ha TH, Cha B, et al. Review of Cohort Studies for Mood Disorders. Psychiatry Investig. 2016;13:265–276.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅